
- Telehealth Visits
- Insurance plan information

Michael A. Spinner, MD
Hematology • Hematology Oncology- Telehealth Visits
- Insurance plan information



Michael A. Spinner, MD
Hematology • Hematology Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Michael A. Spinner is a hematologist-oncologist who specializes in caring for patients with blood cancers with a particular focus in Hodgkin's lymphoma and non-Hodgkin's lymphoma. He has extensive experience in treating lymphoma with immunotherapy (treatments that stimulate the immune system to fight cancer), targeted therapies (treatments that target specific cancer cells) and stem cell transplantation. He also has expertise in CAR T-cell therapy, in which the patient's T cells are altered to target and attack cancer cells.
Spinner's research focuses on clinical trials of promising new treatments for patients who have Hodgkin's or non-Hodgkin's lymphoma, especially treatment methods involving immunotherapy and personalized medicine (techniques that tailor treatment to individual patients). He is a co-investigator on several trials of immunotherapies for lymphoma, and he collaborates with leading lymphoma scientists on identifying biomarkers (measurable elements that may indicate disease) to understand which patients may benefit from certain treatments. He is part of multiple lymphoma research efforts within UCSF and works with other academic medical centers around the U.S. and abroad. While at Stanford, he developed a phase II trial of a new immunotherapy combination to treat relapsed Hodgkin's lymphoma.
After earning his bachelor's degree at Emory University, Spinner earned his medical degree at Vanderbilt University School of Medicine. He completed a residency in internal medicine and a fellowship in hematology-oncology at Stanford. He serves on the Hodgkin's lymphoma guidelines committee for the National Comprehensive Cancer Network.
In his free time, Spinner is an avid classical guitarist. On his YouTube channel, Michael Spinner Guitar, he posts videos in which he plays a variety of music, including Bach, Brazilian jazz and the Beatles.
Education & training
Board certification
- Hematology, American Board of Internal Medicine/Hematology
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, Stanford Hospital and Clinics
Residency
- Internal Medicine, Stanford University Medical Center-GME
Degree
- MD, Vanderbilt University School of Medicine
My expertise
Specialties
Locations
My research
Clinical trials
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin LymphomasOpens in a new window
Recruiting
Evaluate the safety and tolerability of ATG-031
Publications
Showing 1-6 of 57 reviews
- March 23, 20265 out of 5 Stars
We always feel that we are in good hands with Dr Spinner.
- March 19, 20265 out of 5 Stars
I appreciate the expertise and kindness of my hematologist.
- March 12, 20265 out of 5 Stars
All doctors & staff I encountered on my visit were professional, easy to talk to & thorough in describing diagnosis, treatments, and follow up. Dr. Spinner was exceptional in describing diagnosis in an easy-to-understand way.
- March 2, 20265 out of 5 Stars
I've now reached the end of my active treatment and am moving on to the survivorship clinic. I cannot find words to adequately convey how thankful I am to be a patient at UCSF, and specifically a patient of Dr. Spinner in the UCSF Hematology clinic. My care has been exceptional.
- March 1, 20265 out of 5 Stars
Dr Spinner is absolutely amazing and our family is so thankful he is in charge of our mother's care.
- February 18, 20265 out of 5 Stars
Very good is not enough. He is overall outstanding.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.